| Infectious entry pathway of adenovirus type 2 MJ Varga, C Weibull, E Everitt Journal of virology 65 (11), 6061-6070, 1991 | 231 | 1991 |
| T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles AG Wingren, E Parra, M Varga, T Kalland, HO Sjogren, G Hedlund, ... Critical Reviews™ in Immunology 37 (2-6), 2017 | 228 | 2017 |
| An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). A Tikoo, M Varga, V Ramesh, J Gusella, H Maruta Journal of Biological Chemistry 269 (38), 23387-23390, 1994 | 186 | 1994 |
| Novel conserved hydrolase domain in the CLCA family of alleged calcium‐activated chloride channels K Pawłowski, M Lepistö, N Meinander, U Sivars, M Varga, E Wieslander Proteins: Structure, Function, and Bioinformatics 63 (3), 424-439, 2006 | 80 | 2006 |
| The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. M Fridman, A Tikoo, M Varga, A Murphy, MS Nur-E-Kamal, H Maruta Journal of Biological Chemistry 269 (48), 30105-30108, 1994 | 69 | 1994 |
| Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR. P Antonsson, AG Wingren, J Hansson, T Kalland, M Varga, M Dohlsten Journal of immunology (Baltimore, Md.: 1950) 158 (9), 4245-4251, 1997 | 42 | 1997 |
| Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding E Parra, M Varga, G Hedlund, T Kalland, M Dohlsten Molecular and cellular biology 17 (3), 1314-1323, 1997 | 41 | 1997 |
| The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. MS Nur-E-Kamal, M Varga, H Maruta Journal of Biological Chemistry 268 (30), 22331-22337, 1993 | 39 | 1993 |
| HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase J Evenäs, F Edfeldt, M Lepistö, N Svitacheva, A Synnergren, B Lundquist, ... Bioorganic & Medicinal Chemistry Letters 24 (5), 1315-1321, 2014 | 38 | 2014 |
| pH-dependent exposure of endoproteolytic cleavage sites of the adenovirus 2 hexon protein E Everitt, MJ Persson, C Wohlfart FEMS microbiology letters 49 (2), 229-233, 1988 | 34 | 1988 |
| Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity MJ Varga, T Bergman, E Everitt Journal of virology 64 (9), 4217-4225, 1990 | 24 | 1990 |
| Purification of infectious pancreatic necrosis virus by anion exchange chromatography increases the specific infectivity A Carlsson, J Kuznar, M Varga, E Everitt Journal of virological methods 47 (1-2), 27-35, 1994 | 18 | 1994 |
| Nur-E-Kamal MSA and Maruta H.(1994) M Fridman, A Tikoo, M Varga, A Murphy J. Biol. Chem 269, 30105-30108, 0 | 17 | |
| Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors. E Parra, M Varga, M Sigvardsson, G Hedlund, T Kalland, T Leanderson, ... Journal of immunology (Baltimore, Md.: 1950) 155 (3), 1132-1140, 1995 | 14 | 1995 |
| Enhancement of intracellular uncoating of adenovirus in HeLa cells in the presence of benzyl alcohol as a membrane fluidizer Y Blixt, MJ Varga, E Everitt Archives of virology 129, 265-277, 1993 | 14 | 1993 |
| A capture enzyme-linked immunosorbent assay for virus infectivity titrations as exemplified in an adenovirus system E Everitt, MJ Varga Journal of Immunoassay and Immunochemistry 14 (1-2), 1-19, 1993 | 4 | 1993 |
| THE TUMOR SUPPRESSORS NF1 AND NF2-ACTIONS AND FUNCTIONAL DOMAINS H MARUTA, M VARGA, V RAMESH, J GUSELLA JOURNAL OF CELLULAR BIOCHEMISTRY, 190-190, 1994 | | 1994 |
| Studies on the entry pathway of adenovirus type 2. M Varga | | 1993 |
Matti LepistöRIA iMed AstraZenecaVerified email at astrazeneca.com
